North America Coronary Stents Market (2018 - 2024)

North America Coronary Stents Market (2018 - 2024)

  • November 2018 •
  • 68 pages •
  • Report ID: 4407729 •
  • Format: PDF
The North America Coronary stents Market would witness market growth of 7.2% CAGR during the forecast period (2018 – 2024). The coronary market has new trends such as bioresorbable stents, scaffolds, biodegradable polymer, and bifurcation stent. Along with such latest trends, adoption of newer techniques and minimally invasive procedures are further adding to the trend and are an effective alternative for invasive bypass surgery. Also, when used in minimally invasive procedures, the newer technologies offer distinctive advantages over conventional surgeries such as shorter scars, shorter recovery time, less physical trauma and less bleeding & risk of infection.

Based on Product Type, the market is segmented into Drug-eluting stents (DES), Bare-Metal Stents and Bioresorbable Vascular Scaffold. Drug-eluting stents (DES) are further classified into Polymer Based Coatings and Polymer Free Coatings. Polymer Free Coatings is segmented into Micro Structured Surface, Micro porous Surface, Slotted Tubular Surface and Nanoporous Surface. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.